Navigation Links
Liver Fibrosis-Pipeline Insights, 2014
Date:9/3/2014

s, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions
Table of Contents
- Liver Fibrosis Overview
- Liver Fibrosis Pipeline Therapeutics
- Liver Fibrosis Therapeutics under Development by Companies
- Liver Fibrosis Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Liver Fibrosis Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Liver Fibrosis Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Liver Fibrosis Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Liver Fibrosis – Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Liver Fibrosis – Discontinued Products
- Liver Fibrosis – Dormant Products
- Companies Involved in Therapeutics Development for Liver Fibrosis
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Liver Fibrosis, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Liver Fibrosis Assessment by Monotherapy Products
- Liver Fibrosis Assessment by Combination Products
- Liver Fibrosis Assessment by Route of Administration '/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Liver Transplantation-Pipeline Insights, 2014
2. BioDelivery Sciences to Ring The NASDAQ Stock Market Opening Bell
3. Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan
4. Needle-Free Delivery: Technology and Market Forecast 2014-2024
5. Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org
6. Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis
7. Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients
8. ResMeds New AirSense 10 CPAP and APAP Devices Deliver Superior Patient Comfort and Cost-Saving Efficiency for Healthcare Providers
9. Coloplast Delivers On Ambitious Targets With Solid Interim Report
10. Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results
11. BioDelivery Sciences Announces BEMA Buprenorphine NDA Submission on Track following Pre-NDA Meeting with FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Colo. , Oct. 20, 2014  Luoxis ... (NYSE MKT: AMPE), today announced that its academic ... clinical and research potential for its novel RedoxSYS ... potential (ORP) in the body in response to ... value of ORP as a clinical marker will ...
(Date:10/20/2014)... 2014 Valeritas, Inc., a leader in simple, ... Type 2 diabetes, announced today that it has received ... award was presented October 16 th at Cardinal,s ... . The Cardinal Health Supply ... of metrics specifically targeted at the importance of developing ...
(Date:10/20/2014)... , Oct. 20, 2014  AnaptysBio, Inc., a ... antibodies, today announced the appointment of Marco ... Londei will lead the preclinical and clinical development ... "We are pleased to welcome Dr. Londei to ... , President and Chief Executive Officer of AnaptysBio. ...
Breaking Medicine Technology:Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2
... Oct. 28, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Paul Bisaro, Watson,s President and Chief Executive Officer, will provide ... 2011 Annual Credit Suisse Health Care Conference on Wednesday, November ... the Arizona Biltmore Hotel in Phoenix. The presentation will be ...
... Pharma, LLC. is pleased to announce today the presentation ... and completed analysis of a Phase I study of ... stabilized analogue of endomorphin 1, a naturally occurring pain ... in normal healthy volunteers with additional pharmacodynamic end points.  ...
Cached Medicine Technology:
(Date:10/22/2014)... (PRWEB) October 22, 2014 Best Cheap ... in the world. The site has recently announced that ... hosting supplier for people from around the world. , ... in operation today and is providing various kinds of ... the company insists on offering excellent customer service and ...
(Date:10/22/2014)... 2014 Although there are only 24 hours in ... people who have trouble finding time within their busy schedules for ... long periods of time to get in shape. Here are five ... the go. , Change Up Your Commute , Consider riding ... add some exercise into your daily routine. If you must use ...
(Date:10/22/2014)... MA (PRWEB) October 22, 2014 ... new solutions for the treatment of bacterial infections, microbial ... Sinskey has joined its board of directors. , ... and Engineering Systems at The Massachusetts Institute of Technology, ... MIT faculty since 1968. Dr. Sinskey also holds positions ...
(Date:10/22/2014)... (HealthDay News) -- Two sisters in high school have ... Ilina and Medha Krishen use electronic stethoscopes, which electronically ... in breathing patterns or heartbeats. Ilina, a senior ... to find a way to detect early lung damage ... electronic stethoscope, Ilina recorded one breath cycle each from ...
(Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- Measures taken by ... in Ebola-ravaged Liberia may have limited the spread of ... report. The Firestone Natural Rubber Co. provides health ... residents of nearby densely populated communities. Between Aug. ... suspected Ebola cases among those 80,000 people. That incidence ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
... are less prevalent than thought. However, when they do ... characteristics measured as early as five months, according to a ... SLEEP. , The study, led by Valrie Simard, under the ... sampled 987 children in the Province of Quebec, who were ...
... Forest University Baptist Medical Center suggests that a three-drug ... glioblastoma multiforme (GBM), a type of brain tumor with ... been developed, and the team is working on the ... cells and spare healthy brain., Waldemar Debinski, M.D., Ph.D., ...
... ... Boards Merge, CANTON, Ohio, Dec. 31 Two county boards have,merged ... Alcohol and Drug Addiction Services Board of Stark County are,now a single ... "The combined Board will create a stronger advocate for people with,mental ...
... YORK, Dec. 31 The holidays are here, which ... drinks like gingerbread,cookies and egg nog! But overindulging in ... on the pounds, it can also take a toll ... from Pharmavite at:, http://media.medialink.com/WebNR.aspx?story=34272 , Registered journalists can ...
... 31 SPX Corporation,(NYSE: SPW ) today ... a,global manufacturer of process equipment and engineered solutions ... APV greatly enhances our process equipment,operations serving key ... Pacific," said Chris Kearney, Chairman, President and CEO ...
... May Be Cost-Effective Method of Screening for Breast Cancer, but ... A cost-effectiveness study of the value of digital mammography breast ... result in sufficient health gains to warrant its increased cost ... women with dense breasts (Article, p. 1). , The study ...
Cached Medicine News:Health News:Preschoolers' nightmares less prevalent, are trait-like and associated with personality 2Health News:Preschoolers' nightmares less prevalent, are trait-like and associated with personality 3Health News:Research suggests new treatment suitable for all patients 2Health News:Research suggests new treatment suitable for all patients 3Health News:Combined Boards Provide Better Care to More Clients More Efficiently 2Health News:SPX Corporation Completes Acquisition of APV 2Health News:Annals of Internal Medicine tip sheet for Jan. 1, 2008, issue 2
... patients with a diseased heart, the only therapy solution ... transplant. However, donor organs are not always readily available. ... are on the waiting list for a donor organ. ... save the life of a patient. On the one ...
The SonoSite MicroMaxx gives you big machine performance in a lightweight package. This laptop-sized, durable unit represents the technology crossover point between hand-carried ultrasound and larger...
... The Nichols Advantage® 25-Hydroxyvitamin D Assay is ... Specialty System. The Nichols Advantage® 25-Hydroxyvitamin D ... of 25-,hydroxyvitamin D (25-OH-D) and other hydroxylated ... plasma to be used as an aid ...
... The CoaguChek Pro is a ... of the coagulation parameters PT, APTT, ... professional use in hospitals and medical ... e.g., in cardiac catheterization laboratories, and ...
Medicine Products: